SYNERGETIC PHARMACEUTICAL COMBINATION FOR CANCER TREATMENT Russian patent published in 2012 - IPC A61K31/337 A61K31/704 A61K31/7068 A61K31/4025 A61P35/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: there are offered a pharmaceutical combination containing a cytotoxic anticancer agent selected from a group containing paclitaxel, docetaxel, doxorubicine and gemcitabine or their pharmaceutically acceptable salt, and at least one cyclin-dependant kinase (CDK) inhibitor of formula , its application for breast cancer, small or non-small cell carcinoma of lung, ovarian cancer, pancreatic cancer, stomach cancer, stomach cancer and hepatocellular carcinoma treatment; application of a version when the cytotoxic anticancer agent and the specified cyclin-dependant kinase (CDK) inhibitor are introduced simultaneously or successively.

EFFECT: there are shown synergetic effects of the declared combination in cancer treatment.

19 cl, 9 dwg, 16 tbl, 21 ex